Folfox plus Bevacizumab and reolysin
I210
Phase 2 small_molecule completed
Quick answer
Folfox plus Bevacizumab and reolysin for Colorectal Cancer is a Phase 2 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Colorectal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed